Literature DB >> 16002325

High-throughput magnetic resonance imaging in mice for phenotyping and therapeutic evaluation.

Patrick McConville1, Jonathan B Moody, Bradford A Moffat.   

Abstract

High-throughput mouse magnetic resonance imaging (MRI) is seeing rapidly increasing demand in development of therapeutics. Recent advances including higher-field systems, new gradient and radio frequency coils and new pulse sequences, coupled with efficient animal preparation and data handling, allow high-throughput MRI under certain protocols. However, with current shifts from anatomic to functional and molecular imaging, innovative technology is required to meet new throughput demands. The first multiple mouse imaging strategies have provided a glimpse of the future state-of-the-art. However, the successful translation of standard clinical MRI technology to preclinical MRI is required to facilitate next-generation high-throughput MRI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002325     DOI: 10.1016/j.cbpa.2005.06.004

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  8 in total

1.  Small-animal MRI: signal-to-noise ratio comparison at 7 and 1.5 T with multiple-animal acquisition strategies.

Authors:  Olivier Beuf; Franck Jaillon; Hervé Saint-Jalmes
Journal:  MAGMA       Date:  2006-09-07       Impact factor: 2.310

Review 2.  Computational approaches to phenotyping: high-throughput phenomics.

Authors:  Yves A Lussier; Yang Liu
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  High-throughput in vivo screening of targeted molecular imaging agents.

Authors:  M Karen J Gagnon; Sven H Hausner; Jan Marik; Craig K Abbey; John F Marshall; Julie L Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  Multiple-mouse MRI with multiple arrays of receive coils.

Authors:  Marc S Ramirez; Emilio Esparza-Coss; James A Bankson
Journal:  Magn Reson Med       Date:  2010-03       Impact factor: 4.668

5.  Rapid production of specialized animal handling devices using computer-aided design and solid freeform fabrication.

Authors:  Gabriel P Howles; John C Nouls; Yi Qi; G Allan Johnson
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

6.  ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain.

Authors:  Jia-Jean Yiin; Bo Hu; Paul A Schornack; Raghvendra S Sengar; Kun-Wei Liu; Haizhong Feng; Frank S Lieberman; Shih-Hwa Chiou; Jann N Sarkaria; Erik C Wiener; Hsin-I Ma; Shi-Yuan Cheng
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

7.  Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy.

Authors:  Holly E Holmes; Nick M Powell; Da Ma; Ozama Ismail; Ian F Harrison; Jack A Wells; Niall Colgan; James M O'Callaghan; Ross A Johnson; Tracey K Murray; Zeshan Ahmed; Morten Heggenes; Alice Fisher; M Jorge Cardoso; Marc Modat; Michael J O'Neill; Emily C Collins; Elizabeth M C Fisher; Sébastien Ourselin; Mark F Lythgoe
Journal:  Front Neuroinform       Date:  2017-03-31       Impact factor: 4.081

8.  Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome.

Authors:  Nick M Powell; Marc Modat; M Jorge Cardoso; Da Ma; Holly E Holmes; Yichao Yu; James O'Callaghan; Jon O Cleary; Ben Sinclair; Frances K Wiseman; Victor L J Tybulewicz; Elizabeth M C Fisher; Mark F Lythgoe; Sébastien Ourselin
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.